[Tuberculostatics. General adverse effects].
D000328:Adult; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000633:toxicity; D003523:Cycloserine / Q000009:adverse effects; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000009:adverse effects; D005000:Ethionamide / Q000009:adverse effects; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D007612:Kanamycin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000009:adverse effects; D010118:Oxytetracycline / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D013307:Streptomycin / Q000009:adverse effects; D013882:Thiosemicarbazones / Q000009:adverse effects; D014756:Viomycin / Q000009:adverse effects
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D013882:Thiosemicarbazones; D007612:Kanamycin; D004977:Ethambutol; D003523:Cycloserine; D009355:Neomycin; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D010118:Oxytetracycline; D013307:Streptomycin; D014756:Viomycin
Tuberkulostatika. Allgemeine Nebenwirkungen.